Evidence map›Paper›PMID 39711552›Full record

ArticleResearch square2024

Improving survival models in healthcare: a novel matching approach.

Dimitris Bertsimas, Catherine Ning, Per Eystein Lønning, Hideo Baba, Itaru Endo, Richard Burkhart, Federico N Aucejo, Felix Balzer, Martin E Kreis, Georgios Antonios Margonis

Abstract readPreprint
In one paragraph

Article in Research square, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dimitris BertsimasOperations Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA.
Catherine NingOperations Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA.
Per Eystein LønningDepartment of Clinical Science, University of Bergen, Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Hideo BabaDepartment of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Itaru EndoDepartment of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Richard BurkhartDepartment of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Federico N AucejoDepartment of General Surgery, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Felix BalzerCharité - Universitätsmedizin Berlin, Berlin, Germany.
Martin E KreisDepartment of General and Visceral Surgery, Charité Campus Benjamin Franklin, Berlin, Germany.
Georgios Antonios MargonisOperations Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

We present, to our knowledge, the first methodological study aimed at enhancing the prognostic power of Cox regression models, widely used in survival analysis, through optimized data selection. Our approach employs a novel two-stage mechanism: by framing the prognostic stratum matching problem intuitively, we select prognostically representative patient observations to create a more balanced training set. This enables the model to assign equal attention to distinct prognostic subgroups. We demonstrate the methodology using an observational dataset of 1,799 patients with resected colorectal cancer liver metastases, 1,197 of whom received adjuvant chemotherapy and 602 who did not. In our study, as is current standard practice, the comparator was training prognostic models on the entire cohort (referred to as "model 1"). Models trained on the untreated and treated subgroups, matched through our approach (referred to as "model 3"), showed an improvement of up to 20% in bootstrapped C-indices compared to model 1. Notably, model 3 exhibited superior calibration, with a 6- to 10-fold improvement over model 1. Additional performance metrics aligned with these findings, and robustness was confirmed through bias-corrected bootstrapping. Given the ongoing development of numerous linear prognostic models and the general applicability of our approach to any observational data, this method holds significant potential to impact biomedical research and clinical practice where prognostic models are utilized.

Identifiers

PMID39711552
PMCPMC11661418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.